These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 8781743
21. Pancreatic adenocarcinomas frequently show p53 gene mutations. Scarpa A, Capelli P, Mukai K, Zamboni G, Oda T, Iacono C, Hirohashi S. Am J Pathol; 1993 May; 142(5):1534-43. PubMed ID: 8494051 [Abstract] [Full Text] [Related]
22. p53 and c-erbB-2 protein expression in adenocarcinomas and epithelial dysplasias of the gall bladder. Kamel D, Pääkkö P, Nuorva K, Vähäkangas K, Soini Y. J Pathol; 1993 May; 170(1):67-72. PubMed ID: 8100854 [Abstract] [Full Text] [Related]
23. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women. Gealy R, Zhang L, Siegfried JM, Luketich JD, Keohavong P. Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632 [Abstract] [Full Text] [Related]
24. High frequency of frameshift mutation on p53 gene in Taiwanese with non small cell lung cancer. Chang MY, Chong IW, Chen FM, Wang JY, Cheng TL, Cheng YJ, Sheu CC, Hung SY, Yang MC, Lin SR. Cancer Lett; 2005 May 26; 222(2):195-204. PubMed ID: 15863268 [Abstract] [Full Text] [Related]
25. P53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett's esophagus. Schneider PM, Stoeltzing O, Roth JA, Hoelscher AH, Wegerer S, Mizumoto S, Becker K, Dittler HJ, Fink U, Siewert JR. Clin Cancer Res; 2000 Aug 26; 6(8):3153-8. PubMed ID: 10955797 [Abstract] [Full Text] [Related]
26. Sporadic TP53 transition mutations in chronic cholecystitis are possibly linked to gallbladder carcinogenesis. Yanagisawa N, Yamashita K, Kuba T, Okayasu I. Anticancer Res; 2010 Nov 26; 30(11):4443-9. PubMed ID: 21115891 [Abstract] [Full Text] [Related]
27. Distribution of p53 mutations in esophageal and gastric carcinomas and the relationship with p53 expression. Hanazono K, Natsugoe S, Stein HJ, Aikou T, Hoefler H, Siewert JR. Oncol Rep; 2006 Apr 26; 15(4):821-4. PubMed ID: 16525665 [Abstract] [Full Text] [Related]
28. [Expression of p53 in gallbladder carcinoma and in dysplastic and metaplastic lesions of the surrounding mucosa]. Billo P, Marchegiani C, Capella C, Sessa F. Pathologica; 2000 Aug 26; 92(4):249-56. PubMed ID: 11029885 [Abstract] [Full Text] [Related]
32. Expression of p53 protein in T- and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations. Petit B, Leroy K, Kanavaros P, Boulland ML, Druet-Cabanac M, Haioun C, Bordessoule D, Gaulard P. Hum Pathol; 2001 Feb 26; 32(2):196-204. PubMed ID: 11230707 [Abstract] [Full Text] [Related]
33. Alterations of p53 gene in gallbladder cancer patients of North India. Nigam P, Misra U, Negi TS, Mittal B, Choudhuri G. Trop Gastroenterol; 2010 Feb 26; 31(2):96-100. PubMed ID: 20862982 [Abstract] [Full Text] [Related]
34. Mutated p53 protein expression and proliferative activity in advanced gastric cancer. Ikeguchi M, Saito H, Kondo A, Tsujitani S, Maeta M, Kaibara N. Hepatogastroenterology; 1999 Feb 26; 46(28):2648-53. PubMed ID: 10522058 [Abstract] [Full Text] [Related]
35. Analysis of p53 abnormalities in endoscopic gastric biopsies. Imatani A, Sasano H, Asaki S, Toyota T, Saito M, Masuda T, Nagura H. Anticancer Res; 1996 Feb 26; 16(4A):2049-56. PubMed ID: 8712741 [Abstract] [Full Text] [Related]